KELLY FISCHER: Open Payments
NPI 1093438434 · CALCUTTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 70 payments from 18 companies in 2025. Trend: 2023 $322 · 2024 $553 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $207 |
| ABBVIE INC. | 11 | $198 |
| Novo Nordisk Inc | 13 | $188 |
| PFIZER INC. | 10 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
| Lilly USA, LLC | 3 | $46 |
| Astellas Pharma US Inc | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: Wegovy, VRAYLAR, NURTEC ODT, AIRSUPRA, JARDIANCE, UBRELVY, Ozempic, Kerendia.
Industry payments across OH — which companies pay providers there.
